ABOS vs REGN: Which Stock is Better?
Side-by-side comparison of Acumen Pharmaceuticals Inc and Regeneron Pharmaceuticals Inc in 2026
ABOS
Acumen Pharmaceuticals Inc
$1.86
REGN
Regeneron Pharmaceuticals Inc
$733.78
Key Metrics Comparison
| Metric | ABOS | REGN | Winner |
|---|---|---|---|
| Market Cap | $114.48M | $77.69B | REGN |
| P/E Ratio | N/A | 17.57 | REGN |
| EPS (TTM) | $N/A | $41.71 | REGN |
| Revenue Growth | 0.0% | 0.0% | REGN |
| Gross Margin | -36148.3% | 45.8% | REGN |
Analyze ABOS
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABOS or REGN a better investment?
Comparing ABOS and REGN: Acumen Pharmaceuticals Inc has a market cap of $114.48M while Regeneron Pharmaceuticals Inc has $77.69B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABOS and REGN?
ABOS (Acumen Pharmaceuticals Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABOS or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ABOS or REGN?
REGN has higher revenue growth at 0.0% vs 0.0% for ABOS.
Which company is more profitable: ABOS or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 45.8% compared to -36148.3% for ABOS.
Which is the larger company: ABOS or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.69B compared to $114.48M for ABOS.
Should I buy ABOS or REGN in 2026?
Both ABOS and REGN have investment merit. ABOS trades at $1.86 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABOS and REGN stock?
Key differences: Market Cap ($114.48M vs $77.69B), P/E Ratio (N/A vs 17.6x), Revenue Growth (0.0% vs 0.0%), Gross Margin (-36148.3% vs 45.8%).